Home › Fabry Disease › Georgia
Fabry Disease clinical trials in Georgia
6 studies for Fabry Disease are looking for participants at sites in Georgia.
Cities in Georgia
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
- Emory University School of Medicine, Atlanta
RecruitingPhase 1/2
Ages 18 to 65 · Men · Updated Sep 24, 2026 · NCT06270316A Study of Patients With Fabry Disease (US Specific)
- Emory Genetics, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06906367A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
- Emory Genetics, Atlanta
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 1, 2026 · NCT06904261A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
- Emory Genetics Clinical Trials Center, Atlanta
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Aug 10, 2026 · NCT06328608Fabry Disease Registry & Pregnancy Sub-registry
- Emory University School of Medicine- Human Genetics- Site Number : 840060, Decatur
RecruitingObservational study
All ages · All sexes · Updated Jun 23, 2026 · NCT00196742A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
- Emory University School of Medicine, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 14, 2025 · NCT06663358From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.